Slingshot members are tracking this event:

Actinium's (ATNM) Interim Results of Iomab-B in Acute myeloid leukemia (AML) from Pivotal Phase 3 SIERRA Trial due for Monday, October 28th

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ATNM Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sierra, Bone Marrow Transplantation, Iomab-b, Acute Myeloid Leukemia